Kraig delivers first dragon silk fibre to medical firm

23 Aug '17

2 min read

Kraig Biocraft Laboratories, Inc. a leading developer of genetically engineered spider silk based fibre technologies, has delivered the first dragon silk fibres to a medical equipment firm for performance and application suitability testing. Kraig is a biotechnology company focused on the commercialisation of new textiles and high performance fibres.

The Company is dedicating its current dragon silk production to fulfilling its recently exercised US Army contract, but in recognition of the abundant sample requests that the company received and due to this healthcare firm’s extensive expertise in medical technology development and innovation, the company decided to supply a small amount of fibres, to be tested for strength, elasticity, and other properties.

Kraig CEO and founder Kim Thompson said, “It seems like we learn about amazing new potential spider silk medical breakthroughs on a near weekly basis, so we believe that medical technologies will be a very important space for Kraig’s future. As the promise of our fibres becomes increasingly evident, the tests will allow engineers and product designers to understand our fibres’ unique properties, work to define specific opportunities, and accelerate future fibre innovation.”

Jon Rice, Kraig COO said, “It’s important to note that much of this research is for a commonplace application and it’s in very early stages, yet we hope that the tests help in guiding us in building the blueprint for future fibre designs. Based upon the initial evaluation of the fibres we are already working to modify the properties of the finished threads for these applications.” (GK)

Fibre2Fashion News Desk – India

More Textiles News - United States Of America...